Search research articles
Contact Us
Filters
Showing results (21-30 of 462) with videos related to
Page
of 47
Sort By:
Annals of the Rheumatic Diseases
|
May 10, 2019
Response to: 'Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco <i>et al</i>' by Knitza <i>et al</i>
Anna Tjärnlund, Ingrid E Lundberg
Current Opinion in Rheumatology
|
November 13, 1998
New developments in the role of cytokines and chemokines in inflammatory myopathies
I E Lundberg, P Nyberg
Autoimmunity
|
June 14, 2006
Cytokines in idiopathic inflammatory myopathies
Stina Salomonsson, Ingrid E Lundberg
Autoimmunity
|
October 30, 2009
Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies
Cecilia Grundtman, Ingrid E Lundberg
Annals of the Rheumatic Diseases
|
December 17, 2017
Response to: '2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?' by Malaviya
Ingrid E Lundberg, Anna Tjärnlund
Rheumatic Diseases Clinics of North America
|
January 1, 2003
Possible pathogenic mechanisms in inflammatory myopathies
Ingrid E Lundberg, Maryam Dastmalchi
Current Opinion in Rheumatology
|
December 23, 2011
Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies
Helene Alexanderson, Ingrid E Lundberg
Current Opinion in Rheumatology
|
February 17, 2017
International collaboration including patients is essential to develop new therapies for patients with myositis
Ingrid E Lundberg, Jiri Vencovsky
Lakartidningen
|
May 13, 2005
[Temporal arteritis]
Eva Bornefalk, Ingrid E Lundberg
Current Treatment Options in Rheumatology
|
January 8, 2019
Current Treatment for Myositis
Simone Barsotti, Ingrid E Lundberg
Page
of 47
Search research articles
Search
Showing results (21-30 of 462) with videos related to
Sort By:
Page
of 47
Annals of the Rheumatic Diseases
|
May 10, 2019
Response to: 'Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco <i>et al</i>' by Knitza <i>et al</i>
Anna Tjärnlund, Ingrid E Lundberg
Current Opinion in Rheumatology
|
November 13, 1998
New developments in the role of cytokines and chemokines in inflammatory myopathies
I E Lundberg, P Nyberg
Autoimmunity
|
June 14, 2006
Cytokines in idiopathic inflammatory myopathies
Stina Salomonsson, Ingrid E Lundberg
Autoimmunity
|
October 30, 2009
Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies
Cecilia Grundtman, Ingrid E Lundberg
Annals of the Rheumatic Diseases
|
December 17, 2017
Response to: '2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?' by Malaviya
Ingrid E Lundberg, Anna Tjärnlund
Rheumatic Diseases Clinics of North America
|
January 1, 2003
Possible pathogenic mechanisms in inflammatory myopathies
Ingrid E Lundberg, Maryam Dastmalchi
Current Opinion in Rheumatology
|
December 23, 2011
Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies
Helene Alexanderson, Ingrid E Lundberg
Current Opinion in Rheumatology
|
February 17, 2017
International collaboration including patients is essential to develop new therapies for patients with myositis
Ingrid E Lundberg, Jiri Vencovsky
Lakartidningen
|
May 13, 2005
[Temporal arteritis]
Eva Bornefalk, Ingrid E Lundberg
Current Treatment Options in Rheumatology
|
January 8, 2019
Current Treatment for Myositis
Simone Barsotti, Ingrid E Lundberg
Page
of 47